当前位置: X-MOL 学术Diabetes Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank.
Diabetes Care ( IF 14.8 ) Pub Date : 2020-04-01 , DOI: 10.2337/dc19-1836
Hao Ma 1 , Xiang Li 1 , Tao Zhou 1 , Dianjianyi Sun 1, 2 , Zhaoxia Liang 1, 3 , Ying Li 4 , Yoriko Heianza 1 , Lu Qi 5, 6, 7
Affiliation  

OBJECTIVE Glucosamine is a widely used supplement typically taken for osteoarthritis and joint pain. Emerging evidence suggests potential links of glucosamine with glucose metabolism, inflammation, and cardiometabolic risk. We prospectively analyzed the association of habitual glucosamine use with risk of type 2 diabetes (T2D) and assessed whether genetic susceptibility and inflammation status might modify the association. RESEARCH DESIGN AND METHODS This study analyzed 404,508 participants from the UK Biobank who were free of diabetes, cancer, or cardiovascular disease at baseline and completed the questionnaire on supplement use. Cox proportional hazards models were used to evaluate the association between habitual use of glucosamine and risk of incident T2D. RESULTS During a median of 8.1 years of follow-up, 7,228 incident cases of T2D were documented. Glucosamine use was associated with a significantly lower risk of T2D (hazard ratio 0.83, 95% CI 0.78-0.89) after adjustment for age, sex, BMI, race, centers, Townsend deprivation index, lifestyle factors, history of disease, and other supplements use. This inverse association was more pronounced in participants with a higher blood level of baseline C-reactive protein than in those with a lower level of this inflammation marker (P-interaction = 0.02). A genetic risk score for T2D did not modify this association (P-interaction = 0.99). CONCLUSIONS Our findings indicate that glucosamine use is associated with a lower risk of incident T2D.

中文翻译:

氨基葡萄糖的使用,炎症和遗传易感性以及2型糖尿病的发病率:英国生物库中的一项前瞻性研究。

目的氨基葡萄糖是广泛用于骨关节炎和关节痛的补充剂。越来越多的证据表明,葡萄糖胺与葡萄糖代谢,炎症和心脏代谢风险的潜在联系。我们前瞻性分析了习惯性使用氨基葡萄糖与2型糖尿病(T2D)风险的关联,并评估了遗传易感性和炎症状态是否可能改变了关联。研究设计和方法这项研究分析了来自英国生物库的404,508名参与者,他们在基线时没有糖尿病,癌症或心血管疾病,并完成了补充剂使用调查表。使用Cox比例风险模型评估惯常使用葡萄糖胺与发生T2D风险之间的关联。结果在平均8.1年的随访期间,7 记录了228起T2D事件。在调整了年龄,性别,BMI,种族,中心,汤森剥夺指数,生活方式因素,疾病史和其他补品后,使用氨基葡萄糖与T2D的风险显着降低(危险比0.83,95%CI 0.78-0.89)。采用。在血液中基线C反应蛋白水平较高的参与者中,这种反向关联要比在炎症标记水平较低的参与者中更为明显(P相互作用= 0.02)。T2D的遗传风险评分并未改变这种关联(P相互作用= 0.99)。结论我们的研究结果表明,使用氨基葡萄糖与较低的T2D风险相关。汤森剥夺指数,生活方式因素,疾病史和其他补品使用情况。在血液中基线C反应蛋白水平较高的参与者中,这种反向关联要比在炎症标记水平较低的参与者中更为明显(P相互作用= 0.02)。T2D的遗传风险评分并未改变这种关联(P相互作用= 0.99)。结论我们的研究结果表明,使用氨基葡萄糖与较低的T2D风险相关。汤森剥夺指数,生活方式因素,疾病史和其他补品使用情况。在血液中基线C反应蛋白水平较高的参与者中,这种反向关联要比在炎症标记水平较低的参与者中更为明显(P相互作用= 0.02)。T2D的遗传风险评分并未改变这种关联(P相互作用= 0.99)。结论我们的研究结果表明,使用氨基葡萄糖与较低的T2D风险相关。T2D的遗传风险评分并未改变这种关联(P相互作用= 0.99)。结论我们的研究结果表明,使用氨基葡萄糖与较低的T2D风险相关。T2D的遗传风险评分并未改变这种关联(P相互作用= 0.99)。结论我们的研究结果表明,使用氨基葡萄糖与较低的T2D风险相关。
更新日期:2020-04-20
down
wechat
bug